Abstract
Growing evidence in the medical literature has linked the COVID-19 vaccine as a potential trigger for the development or exacerbation of various autoimmune rheumatic diseases. To the best of our knowledge, we report one of the first cases of seropositive rheumatoid arthritis diagnosed after the messenger RNA COVID-19 vaccine.
Keywords
Publication details
- DOI
- 10.5001/omj.2024.06
- Journal
- Oman Medical Journal
- Publisher
- Oman Medical Specialty Board
- Open access
- Gold open access
Cite this article
APA 7
Almouslem, A., Al Lawati, T., Al Shirawi, A., & Al-Amri, U. (2024). New-onset Seropositive Rheumatoid Arthritis Post-mRNA COVID-19 Vaccine: A Case Report. Oman Medical Journal. https://doi.org/10.5001/omj.2024.06
MLA 9
Almouslem, Amanda, et al. "New-onset Seropositive Rheumatoid Arthritis Post-mRNA COVID-19 Vaccine: A Case Report." Oman Medical Journal, 2024. https://doi.org/10.5001/omj.2024.06.
Chicago (author–date)
Almouslem, Amanda, Talal Al Lawati, Ali Al Shirawi, and Usama Al-Amri. 2024. "New-onset Seropositive Rheumatoid Arthritis Post-mRNA COVID-19 Vaccine: A Case Report." Oman Medical Journal. https://doi.org/10.5001/omj.2024.06.
Harvard
Almouslem, A., Al Lawati, T., Al Shirawi, A. and Al-Amri, U. (2024) 'New-onset Seropositive Rheumatoid Arthritis Post-mRNA COVID-19 Vaccine: A Case Report', Oman Medical Journal. doi:10.5001/omj.2024.06.
Vancouver
Almouslem A, Al Lawati T, Al Shirawi A, Al-Amri U. New-onset Seropositive Rheumatoid Arthritis Post-mRNA COVID-19 Vaccine: A Case Report. Oman Medical Journal. 2024. doi:10.5001/omj.2024.06
IEEE
A. Almouslem, T. Al Lawati, A. Al Shirawi, and U. Al-Amri, "New-onset Seropositive Rheumatoid Arthritis Post-mRNA COVID-19 Vaccine: A Case Report," Oman Medical Journal, 2024, doi: 10.5001/omj.2024.06.